ROIV

Roivant Sciences
ROIV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$8.19B
EV
$4.25B
Shares Outstanding
723.93M
Beta
1.15

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$17.11
P/E 2026E
-
P/Revenue 2026E
275.26x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Roivant Sciences Ltd.

gainify
ROIV

Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies fo...

Sector

Healthcare

Industry

Biotechnology

CEO

Gline, Matthew

Employees

750

IPO Date

2020-12-08

Headquarters

50 Broadway, 7th Floor, London, Greater London, SW1H 0DB, United Kingdom

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.